Prelude Capital Management, LLC Inovio Pharmaceuticals, Inc. Call Options Transaction History

Prelude Capital Management, LLC

  • $1.39 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$8.5 - $12.85 $68,000 - $102,800
-8,000 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$9.57 - $27.05 $6,699 - $18,935
-700 Reduced 8.05%
8,000 $93,000
Q2 2020

Aug 14, 2020
SELL
$7.14 - $31.69 $22,134 - $98,239
-3,100 Reduced 26.27%
8,700 $234,000
Q1 2020

May 15, 2020
BUY
$2.98 - $14.09 $35,164 - $166,262
11,800 New
11,800 $88,000

Others Institutions Holding INO

# of Institutions
10
Shares Held
281K
Call Options Held
0
Put Options Held
0
View Full List

About INOVIO PHARMACEUTICALS, INC.

INO Quotes by TradingView
  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $1.41B
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email